Group B streptococcal necrotizing pneumonia in a diabetic patient adult

PACHA A; LUNA CIAN R; BONOFIGLIO L; SOLARI M; STRADA V; SUAREZ M; VIGLIAROLO L; TERSIGNI C; MOLLERACH M; LOPARDO H

REVISTA ARGENTINA DE MICROBIOLOGíA

ASOCIACION ARGENTINA MICROBIOLOGIA

Lugar: Buenos Aires; Año: 2017

0325-7541

The aim of this report is to describe a rare case of necrotizing pneumonia due to Streptococcus agalactiae serotype III in a relatively younger adult (48 y-o) diabetic male patient. The organism was isolated from the pleural fluid and was only resistant to tetracycline. The patient firstly received ceftazidime (2g/8h iv.) + clindamycin (300 mg/8h.) during 18 days and then he was discharged home and orally treated with amoxicillin clavulanic acid (1g/12h) during 23 days with an uneventful evolution. As in cases of invasive infection by Streptococcus pyogenes, is posible that clindamycin could prevent the streptococcal toxic shock syndrome.